Sialylation of lacto-N-neotetraose (LNnT) extending from heptose I (HepI) of 23 gonococcal lipooligosaccharide (LOS) contributes to pathogenesis. Previously, 24 gonococcal LOS sialyltransterase (Lst) was shown to sialylate LOS in Triton X-100 25 extracts of strain 15253, which expresses lactose from both HepI and HepII, the minimal 26 structure required for mAb 2C7 binding. Ongoing work has shown that growth of 15253 27 in cytidine monophospho-N-acetylneuraminic acid (CMP-Neu5Ac)-containing media 28 enables binding to CD33/Siglec-3, a cell surface receptor that binds sialic acid, 29 suggesting that lactose termini on LOS of intact gonococci can be sialylated. Neu5Ac 30 was detected on LOSs of strains 15253 and a MS11 mutant with only lactose from HepI 31 and HepII by mass spectrometry; deleting HepII lactose rendered Neu5Ac undetectable.
Introduction 45
Gonorrhea affects about 78 million people annually worldwide (1); almost 46 470,000 of these are reported in the U.S. Multidrug-resistant gonorrhea has been 47 MS11 LOS mutants (Fig. 5) . The sialylatable 3-Hex and 4-Hex strains served as 140 controls for Neu5Ac-mediated complement inhibition. Growth in media containing Neu5Ac decreased C3 deposition all tested strains. Similar to 15253, sialylation of 142 MS11 2-Hex/G+ also inhibited C3 deposition. In contrast to 15253/G-, we noted a 143 reproducible decrease in C3 deposition on the 2-Hex/G-mutant, suggesting that 144 Neu5Ac was also added to the LOS of this strain. The degree of inhibition seen with 145 sialylation of MS11 2-Hex/G-(a 4.1-fold decrease compared to the unsialylated parent, 146 and 7.3-fold above baseline conjugate control levels) was less than that seen with To discern the sialic acid linkage to HepII substituted lactose we examined the 153 effect of α2-3-linkage-specific neuraminidase on mouse C3 deposition (Fig. 6) . 154 Sialylated 2-Hex/G+ and the corresponding wild-type strain 15253 that possessed the 155 same pattern of Hep I and Hep II hexose substitutions, failed to show increased C3 156 deposition after treatment with recombinant α2-3-specific sialidase followed by 157 incubation with 15% normal mouse serum; resistance to α2-3-sialidase suggests an α2-158 6 linkage. structure required for mAb 2C7 binding are lactoses simultaneously extending from both 176 HepI and HepII. Glycan extensions beyond lactose on HepII, for example with Gal seen in a mutant strain selected under pyocin pressure called JW31R, abrogates 178 mAb 2C7 binding (53). We therefore asked whether sialylation of HepII lactose affected 179 mAb 2C7 binding and function. While sialylation of 15253 did not affect mAb 2C7 (42). We examined a collection of minimally (≤3) passaged isolates 202 cultured from the female contacts of men with gonorrhea who were referred to a STD 203 clinic in Nanjing, China, for expression of the 2C7 LOS epitope by whole cell ELISA. We 204 also examined isolates for their ability to bind to mAb L8 (recognizes an epitope defined We next assessed the ability of mAb 2C7 to mediate complement-dependent 211 bactericidal activity against the first 62 of 75 isolates collected from men with urethritis in 212 a Nanjing (China) study of gonococcal transmission from men to women. Because 213 some of the strains were sensitive to killing by 16.7% pooled normal human serum 214 (NHS) that was used as the complement source, all isolates were grown in media 215 containing 2 µg/ml CMP-Neu5Ac to render them fully serum resistant (>100% survival).
216
All (100%) of isolates were killed >50% in the presence of 5 µg/ml of mAb 2C7 and 217 NHS. This included two of four isolates that bound very low levels of mAb 2C7 by ELISA 218 (OD 450nm between 0.065 and 0.090). Further, serum bactericidal activity correlated with 219 levels of mAb 2C7 binding ( Fig. 10C ). are not aware of any naturally occurring gonococcal isolate that lacks lgtG. We have 263 shown previously that a lgtG deletion mutant of N. gonorrhoeae FA1090 was less 264 virulent than its wild-type parent (43). Lam and Gray-Owen showed that serial passage 265 of N. gonorrhoeae in mice resulted an increased fraction of mice infected with each 266 13 subpassage and in a reproducible selection of variants with lgtG 'on', providing further 267 strong evidence of the importance of HepII lactose expression in vivo (65). 268 We noted that MS11 2-Hex/G-inhibited mouse complement when grown in from whole blood that was clotted at 25 °C for 30 min followed by centrifugation at 1500 336 g for 20 min at 4 °C. Serum from 10 donors was pooled, aliquoted and stored at -80 °C. ranging from 0 to 100 µg/ml in half-log 10 increments; susceptibility to mAb 2C7 (5 µg/ml) 377 was determined by serum bactericidal assay as described previously (72) given subcutaneously on each of three days; −2, 0 and +2 days (before, the day of and 419 after inoculation) to prolong the estrus phase of the reproductive cycle and promote 420 susceptibility to Ng infection. Antibiotics (vancomycin, colistin, neomycin, trimethoprim 421 and streptomycin (VCNTS)) ineffective against N. gonorrhoeae were also used to 422 reduce competitive microflora (7). Mice (n=10/group) were infected on Day 0 with either 423 strain 15253, 15253/G-or 15253 Δlst (inoculum specified for each experiment).
424
Vaginas were swabbed daily and plated on chocolate agar containing VCNTS to 425 enumerate N. gonorrhoeae CFUs. The efficacy of mAb 2C7 in vivo against 15253 was 426 performed in wild-type BALB/c mice (Jackson Laboratories) as described previously.
427
Mice were treated with mAb 2C7 or control mouse IgG3 intraperitoneally, 10 µg twice a 428 21 day on days -2, -1 (prior to) and 0 (the day of infection with strain 15253 and daily 429 vaginal CFU enumeration was carried out as described above. populations rank test was also applied to compare more than two groups in an 448 experiment. Correlation between survival in serum bactericidal assays and mAb 2C7 
